Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1.
A 2-yr and 9-month-old female patient with neurofibromatosis type-1 presented with hepatomegaly, anemia, thrombocytopenia, and croupy cough and diagnosed with xanthogranuloma disseminatum (XD). She failed chemotherapy consisting of steroids, 6-mercaptopurine and methotrexate. A partial response to HLH-94 therapy that included etoposide and cyclosporine A was initially observed. However, she continued to have significant organ dysfunction without further improvement at 6 months of therapy. She then received matched unrelated donor bone marrow transplantation (BMT) following carmustine, etoposide, cytarabine and melphelan conditioning with complete resolution of symptoms. BMT is an option in therapy-resistant, life threatening XD cases.
Savaşan
Süreyya
S
Division of Hematology/Oncology, Children's Hospital of Michigan, MI 48201, USA. ssavasan@med.wayne.edu
Smith
Laurie
L
Scheer
Carolyn
C
Dansey
Roger
R
Abella
Esteban
E
D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D005260:Female; D006801:Humans; D009456:Neurofibromatosis 1 / Q000150:complications*; D019172:Transplantation Conditioning; D014972:Xanthogranuloma, Juvenile / Q000209:etiology / Q000628:therapy*